Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 August 2025 | Story Onthatile Tikoe and the Centre for Teaching and Learning | Photo Supplied
CTL
From the left: Dr Jenny Glennie (SAIDE), Gugu Khanye (Director: Student Success – UFS), Prof Matete Madiba (Deputy Vice-Chancellor – UWC), Prof Francois Strydom (UFS Siyaphumelela Lead), and Prof Nthabiseng Ogude (Siyaphumelela Institutional Coach) at the 2025 Siyaphumelela Conference. The group played a key role in advancing conversations around student success, collaboration, and innovation in higher education.

The University of the Free State (UFS) is advancing a transformative approach to student success that positions it to become a national leader in enhancing social mobility. This vision was underscored at the 2025 Siyaphumelela Conference, where the university shared details of its groundbreaking collaboration with the National Institute for Student Success (NISS) at Georgia State University (GSU) in the United States.

Prof Francois Strydom, Senior Director: Centre for Teaching and Learning (CTL), explained that the initiative builds on lessons from GSU’s remarkable achievements. “The success of Georgia State University has been truly inspiring,” he said. “The NISS approach, which focuses on using data to dismantle systemic barriers and improve graduation rates, has transformed outcomes for a predominantly low-income and diverse student body. By contextualising this data-driven model for our environment, the UFS is proud to be the first university on the African continent to implement it.”

 

Building on proven success

GSU’s success in eliminating equity gaps in retention and completion among different racial groups was achieved through a redesign of its support structures and processes. Drawing on its own established track record of narrowing equity gaps in success rates, the UFS aims to replicate these outcomes in a way that is tailored to its unique context.

At the conference, the UFS Centre for Teaching and Learning (CTL) launched a new national report on student engagement trends and presented papers on a range of topics. These included innovative strategies for improving performance in high-priority modules, the use of predictive analytics to provide proactive student support, and research into gender differences in academic performance and class attendance in a post-COVID world.

Prof Strydom also led an exploratory panel discussion on strengthening collaboration between universities, business, and philanthropy to drive large-scale student success initiatives. “By facilitating a deeper understanding between philanthropic organisations, businesses, and universities, we can develop innovative and impactful approaches to funding and student support,” he said.

 

Driving innovation and sustainability

The UFS’ contributions at the conference were further reinforced by institutional projects focused on the evidence-based integration of artificial intelligence (AI) into student learning and success. These initiatives reflect a clear commitment to transformation that is both research-led and data-driven.

Looking ahead, Prof Strydom emphasised the opportunity before the institution: “We have a unique opportunity to leverage the lessons learnt from our student success initiatives to guide further research, deploy technology in ways that optimise human connection, and help create responsible societal futures while contributing to the sustainability of our university.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept